NCT05491577

Brief Summary

Charcot foot, characterized by progressive destructive damage to bone, soft tissue and tendons, involving joint dislocation in the ankle and foot, is a complication of diabetes that is still poorly understood by patients and caregivers. The clinical signs are non-specific and it is therefore largely underestimated due to a delay in diagnosis/lack of diagnosis.This study will be on a prospective multicenter cohort of patients with chronic Charcot's foot in France to evaluate the evolution of quality of life at 2 years, as well as predictive factors in order to better identify subjects with the worst outcome among this population. Our hypothesis is that, in patients with chronic Charcot foot, the deterioration in quality of life over time is primarily related to loss of foot and ankle functionality, foot and ankle deformity and the presence of foot wounds/comorbidities/severe diabetic complications.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
21mo left

Started Jan 2023

Longer than P75 for all trials

Geographic Reach
1 country

17 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress66%
Jan 2023Jan 2028

First Submitted

Initial submission to the registry

July 29, 2022

Completed
10 days until next milestone

First Posted

Study publicly available on registry

August 8, 2022

Completed
6 months until next milestone

Study Start

First participant enrolled

January 23, 2023

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 22, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 22, 2028

Last Updated

August 13, 2024

Status Verified

August 1, 2024

Enrollment Period

4.5 years

First QC Date

July 29, 2022

Last Update Submit

August 12, 2024

Conditions

Keywords

Diabetes complicationsDiabetic footOsteoarthropathy

Outcome Measures

Primary Outcomes (6)

  • Results of the SF36 questionnaire at inclusion

    The SF-36 questionnaire is a quality of life questionnaire that includes 36 questions divided into 8 different categories (physical functioning, limitations due to physical condition, physical pain, perceived health, vitality, social functioning or well-being, limitations due to mental condition, mental health). These 8 dimensions are used to calculate two scores on the quality of life of individuals: the physical composite score and the mental composite score. The higher the score, the greater the capacity. It is self-administered and takes less than 10 minutes. Higher scores indicate better quality of life. The French version has been validated and has satisfactory psychometric properties. Score from 0 to 100.

    Day 0

  • Results of the FAAM-F questionnaire at inclusion

    The FAAM is a self-administered questionnaire that measures physical function of the foot and ankle. It is adapted and validated in the evaluation of diabetic foot disease. It consists of an assessment of activity of daily living and a sports assessment. The FAAM has been translated and validated in French. Score from 0 to 100.

    Day 0

  • Results of the SF36 questionnaire at Month 12

    The SF-36 questionnaire is a quality of life questionnaire that includes 36 questions divided into 8 different categories (physical functioning, limitations due to physical condition, physical pain, perceived health, vitality, social functioning or well-being, limitations due to mental condition, mental health). These 8 dimensions are used to calculate two scores on the quality of life of individuals: the physical composite score and the mental composite score. The higher the score, the greater the capacity. It is self-administered and takes less than 10 minutes. Higher scores indicate better quality of life. The French version has been validated and has satisfactory psychometric properties. Score from 0 to 100.

    Month 12

  • Results of the FAAM-F questionnaire at Month 12

    The FAAM is a self-administered questionnaire that measures physical function of the foot and ankle. It is adapted and validated in the evaluation of diabetic foot disease. It consists of an assessment of activity of daily living and a sports assessment. The FAAM has been translated and validated in French. Score from 0 to 100.

    Month 12

  • Results of the SF36 questionnaire at Month 24

    The SF-36 questionnaire is a quality of life questionnaire that includes 36 questions divided into 8 different categories (physical functioning, limitations due to physical condition, physical pain, perceived health, vitality, social functioning or well-being, limitations due to mental condition, mental health). These 8 dimensions are used to calculate two scores on the quality of life of individuals: the physical composite score and the mental composite score. The higher the score, the greater the capacity. It is self-administered and takes less than 10 minutes. Higher scores indicate better quality of life. The French version has been validated and has satisfactory psychometric properties. Score from 0 to 100.

    Month 24

  • Results of the FAAM-F questionnaire at Month 24

    The FAAM is a self-administered questionnaire that measures physical function of the foot and ankle. It is adapted and validated in the evaluation of diabetic foot disease. It consists of an assessment of activity of daily living and a sports assessment. The FAAM has been translated and validated in French. Score from 0 to 100.

    Month 24

Secondary Outcomes (75)

  • A. Evolution of X-ray measurements of bone and joint deformity of the foot. Lisfranc metatarsal misalignment (Méary's Line)

    Day 0

  • A. Evolution of X-ray measurements of bone and joint deformity of the foot. Lisfranc metatarsal misalignment (Méary's Line)

    Month 12

  • A. Evolution of X-ray measurements of bone and joint deformity of the foot. Lisfranc metatarsal misalignment (Méary's Line)

    Month 24

  • A. Evolution of the radiologic measurements of bone and joint deformity of the foot: Méary's angle.

    Day 0

  • A. Evolution of the radiologic measurements of bone and joint deformity of the foot: Méary's angle.

    Month 12

  • +70 more secondary outcomes

Other Outcomes (146)

  • Sex of patients

    Day 0

  • Age of patients

    Day 0

  • Patient's personal situation

    Day 0

  • +143 more other outcomes

Interventions

The SF-36, FAAM-F, PHQ-9, PHQ-2 and the simplified version of the EPICES score questionnaire will all be filled in by the patients.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The source population corresponds to all diabetic patients (Type 1, 2 or secondary diabetes) hospitalized or consulting for chronic diabetic osteoarthropathy of the nerves, without wound managed in the participating centers.

You may qualify if:

  • patients with Type 1 or 2 diabetes or secondary diabetes
  • patient hospitalized or consulting for osteoarthropathy in its chronic stage, without wounds
  • patients affiliated to or beneficiaries of a health insurance scheme.
  • adult patients (≥18 years old).

You may not qualify if:

  • patients with non-diabetic osteoarthropathy of the nerves.
  • patients with acute diabetic osteoarthropathy of the nerves.
  • patients with a foot ulcer
  • patients who have expressed opposition to participating in the study.
  • patients under court protection, guardianship or trusteeship.
  • patients for whom it is impossible to give informed information.
  • pregnant, parturient, or breastfeeding patients.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (17)

Centre Hospitalier de Boulogne-sur-Mer

Boulogne-sur-Mer, Pas-de-Calais, 62200, France

NOT YET RECRUITING

Groupement Hospitalier Est, Hôpital Cardiologique Service de Diabétologie 28 Av du Doyen Lépine

Bron, 69500, France

NOT YET RECRUITING

CH Sud Francilien Service de Diabétologie 40 Avenue Serge Dassault

Corbeil-Essonnes, 91100, France

NOT YET RECRUITING

CHU de Grenoble Service d'Endocrinologie Allée des Sablons Les écrins

Grenoble, 38043, France

NOT YET RECRUITING

Hôpital Hôtel dieu Service d'Endocrinologie 26 rue d'Harfleur

Le Creusot, 71200, France

NOT YET RECRUITING

CHU Bicêtre Service d'Endocrinologie et Maladies de la reproduction 78 rue du Général Leclerc

Le Kremlin-Bicêtre, 94275, France

RECRUITING

CH de Lens Unité de Diabétologie-Endocrinologie- Nutrition-Obésité Centre Hospitalier Dr SCHAFFNER 99 rte de La Bassée,

Lens, 62307, France

RECRUITING

CHRU de Lille Service d'Endocrinologie Diabétologie et Métabolisme, Hôpital Claude Huriez, Rue Polonovski

Lille, 59037, France

NOT YET RECRUITING

CHU de la CONCEPTION Service de Nutrition, Diabétologie, Obésité médicale, chirurgicale 47 Bd Baille

Marseille, 13005, France

NOT YET RECRUITING

CHU de Montpellier Service des Maladies métaboliques 371 av. Doyen Giraud

Montpellier, 34295, France

RECRUITING

GH Pitié Salpétrière Unité de podologie Service de Diabétologie 47-83 Bd de l'Hôpital

Paris, 750013, France

RECRUITING

GH Paris Saint Joseph Service de Diabétologie et Endocrinologie 185 rue Raymond Losserand

Paris, 75014, France

RECRUITING

Hôpital Cochin Service de diabétologie 123 Bd de Port Royal

Paris, 75014, France

NOT YET RECRUITING

CHU de Lyon Sud Service d'Endocrinologie-Diabète-Nutrition CH Lyon Sud Pavillon médical, Bat 1B 165 chemin du Grand Revoyet

Pierre-Bénite, 69495, France

RECRUITING

CHU Reims Service d'Endocrinologie, diabète-nutrition Rue du Général Koenig

Reims, 51092, France

RECRUITING

Hôpitaux Universitaires de Strasbourg Service d'Endocrinologie et Diabétologie 1, place de l'hôpital,

Strasbourg, 61091, France

NOT YET RECRUITING

Hôpital DRON Service de diabétologie 135 rue du Président Coty

Tourcoing, 52208, France

RECRUITING

MeSH Terms

Conditions

Diabetes ComplicationsDiabetic Foot

Interventions

Patient Health Questionnaire

Condition Hierarchy (Ancestors)

Diabetes MellitusEndocrine System DiseasesDiabetic AngiopathiesVascular DiseasesCardiovascular DiseasesFoot UlcerLeg UlcerSkin UlcerSkin DiseasesSkin and Connective Tissue DiseasesDiabetic Neuropathies

Intervention Hierarchy (Ancestors)

Surveys and QuestionnairesData CollectionEpidemiologic MethodsInvestigative TechniquesPsychological TestsBehavioral Disciplines and ActivitiesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 29, 2022

First Posted

August 8, 2022

Study Start

January 23, 2023

Primary Completion (Estimated)

July 22, 2027

Study Completion (Estimated)

January 22, 2028

Last Updated

August 13, 2024

Record last verified: 2024-08

Locations